Stati Uniti INTRA-CELLULAR THERAPIES INC

85,48 -0,19% 13:36 21/11/2024 - ISIN: US46116X1019

Raccomandazioni

Giudizio Emittente Data
+ OVERWEIGHT CANTOR FITZGERALD 31/10/2024
= NEUTRAL GOLDMAN SACHS 30/10/2024
+ OVERWEIGHT MORGAN STANLEY 11/10/2024
- UNDERPERFORM RBC CAPITAL 04/10/2024
+ BUY UBS 04/10/2024
- UNDERPERFORM RBC CAPITAL 06/09/2024
+ BUY UBS 06/09/2024
+ OVERWEIGHT PIPER SANDLER 05/09/2024